Hyphens Pharma International

SINGAPORE (July 10): Hyphens Pharma International has launched its so-called "next generation" Ceradan cream.

SINGAPORE (July 9): Since its IPO in May last year, Hyphens Pharma International, the specialty pharmaceutical and consumer healthcare group, has gradually been building up its presence, both locally and in the region.

SINGAPORE (June 24): Hyphens Pharma International is pursuing a multipronged growth plan. Even as it signs new distribution agreements with other brands, it is developing a steady pipeline of its own products as well. The company’s proprietary product b

SINGAPORE (May 13): Hyphens Pharma International has delivered 1Q19 earnings of $1.4 million, down 20.3% y-o-y from $1.8 million due to lower revenue as well as higher administrative expenses.

SINGAPORE (Mar 1): Hyphens Pharma International has announced earnings of $0.8 million for the 4Q ended Dec 2018, rising 31.9% from $0.6 million in 4Q17 in the absence of one-off IPO expenses incurred from the year before.  

SINGAPORE (May 18): Hyphens Pharma International, the latest healthcare stock making it Catalist debut this morning, opened at 30 cents, 15.4% higher than its IPO price of 26 cents.

SINGAPORE (May 17): Hyphens Pharma International says its public offering of 3 million shares at 26 cents per share in conjunction with its Catalist listing was about 152 times subscribed.

SINGAPORE (Apr 26): Hyphens Pharma International, the specialty pharmaceutical and consumer healthcare group which also owns the Ocean Health brand of supplements, has lodged a preliminary offer document with Singapore Exchange (SGX) to list on its Catali